1. Home
  2. LCUT vs AGEN Comparison

LCUT vs AGEN Comparison

Compare LCUT & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$6.78

Market Cap

131.2M

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.92

Market Cap

178.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
AGEN
Founded
1945
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
131.2M
178.2M
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
LCUT
AGEN
Price
$6.78
$3.92
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$5.00
$14.50
AVG Volume (30 Days)
157.5K
1.2M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
100.00
EPS
N/A
N/A
Revenue
$647,933,000.00
$42,877,086.00
Revenue This Year
$3.74
$107.63
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
$8.89
Revenue Growth
N/A
89.95
52 Week Low
$2.89
$2.71
52 Week High
$8.20
$7.34

Technical Indicators

Market Signals
Indicator
LCUT
AGEN
Relative Strength Index (RSI) 54.91 49.53
Support Level $6.50 $2.96
Resistance Level $8.20 $4.58
Average True Range (ATR) 0.57 0.36
MACD -0.16 -0.08
Stochastic Oscillator 18.13 19.10

Price Performance

Historical Comparison
LCUT
AGEN

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: